Novo Nordisk Stock Crashes 22% After Disappointing Obesity Drug Data. Eli Lilly Shares Soar. Business December 20, 2024 Updated: 12 hours ago By Market Watch Share FacebookTwitterPinterestWhatsApp Novo Nordisk stock fell sharply after the Ozempic maker’s experimental obesity drug CagriSema disappointed investors. Eli Lilly Shares Soar. Read more… Share FacebookTwitterPinterestWhatsApp Latest news Sports Myles Garrett Threatens To End Joe Burrow’s Hope As Browns DE Gives Up in ‘Misery’ essentiallysports.com - December 21, 2024 Entertainment Father of 5 Dies After Running Into House Fire to Save His Family People - December 21, 2024 Entertainment How to Watch SMU vs. Penn State 2024 Playoff Game: Stream Football Rollingstone - December 21, 2024 Videos We Tested 50 Cinnamon Roll Recipes Tasty - December 21, 2024 Related news Business TONIGHT!!! EMERGENCY AT THE WHITE HOUSE! Johnny Bravo - December 21, 2024 Sports Myles Garrett Threatens To End Joe Burrow’s Hope As Browns DE Gives Up in ‘Misery’ essentiallysports.com - December 21, 2024 Entertainment Father of 5 Dies After Running Into House Fire to Save His Family People - December 21, 2024 Entertainment How to Watch SMU vs. Penn State 2024 Playoff Game: Stream Football Rollingstone - December 21, 2024 LEAVE A REPLY Cancel reply Comment: Please enter your comment! Name:* Please enter your name here Email:* You have entered an incorrect email address! Please enter your email address here Website: Save my name, email, and website in this browser for the next time I comment.
